Biocept, Inc. , a leading provider of molecular diagnostic assays, products and services, reports financial results for the three months ended March 31, 2023 and provides a business. | May 10, 2023
StockNews.com assumed coverage on shares of Biocept (NASDAQ:BIOC – Get Rating) in a research report released on Saturday morning. The firm issued a hold rating on the medical research company’s stock. BIOC has been the topic of a number of other reports. Maxim Group cut Biocept from a buy rating to a hold rating in […]
StockNews.com assumed coverage on shares of Biocept (NASDAQ:BIOC – Get Rating) in a research report sent to investors on Friday morning. The brokerage issued a hold rating on the medical research company’s stock. BIOC has been the topic of a number of other reports. Brookline Capital Management cut Biocept from a buy rating to a […]
StockNews.com began coverage on shares of Biocept (NASDAQ:BIOC – Get Rating) in a research report sent to investors on Friday. The firm issued a hold rating on the medical research company’s stock. Other research analysts have also issued research reports about the company. Brookline Capital Management lowered Biocept from a buy rating to a hold […]
Biocept, Inc. (NASDAQ:BIOC – Get Rating) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 224,900 shares, an increase of 40.6% from the March 31st total of 160,000 shares. Based on an average daily volume of 99,000 shares, the days-to-cover […]